300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
Life Science
Food and Beverage
Publishing
LGBT
Mobile Apps
Wine and Spirits
Cannabis
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Celebrity
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Enterprise
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
LATAM
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Ecuador
Bolivia
Italy
Belize
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Belarus
Finland
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Centre for Cellular and Molecular Platforms, VC Fund

Centre for Cellular and Molecular Platforms

VC Fund

Bangalore, India

Centre for Cellular and Molecular Platforms is a VC fund in Bangalore focused on Health Care and Medical. The Centre for Cellular and Molecular Platforms, or C-CAMP an initiative supported by the Department of Biotechnology, Govt of India is an enabler or catalyst of cutting-edge research and innovation in the life sciences since 2009. C-CAMP is also a member of the Bangalore Life Science Cluster (BLiSC). We facilitate Bioscience Research andEntrepreneurship by providing Research, Development, Training, and Services in state-of-the-art Technology Platforms.

Total investments:
8
Last investment:
Lead investor:
13%

Last updated:

Industries Centre for Cellular and Molecular Platforms invests in

Health CareMedicalManufacturingMedical DeviceAgTech

Stages Centre for Cellular and Molecular Platforms invests in

SeedGrantPre-Seed

Countries Centre for Cellular and Molecular Platforms invests in

India

Round sizes

Seed $276k–$3M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$276k–$3M

Investment Focus

Industry

  • Health Care 4 (50%)
  • Medical 2 (25%)
  • Manufacturing 2 (25%)
  • Medical Device 2 (25%)
  • AgTech 1 (13%)
See all 16 industries →

Stage

  • Seed 6 (75%)
  • Grant 1 (13%)
  • Pre-Seed 1 (13%)

Team

NameTitleInvestmentsLinksEmail
Nitya Raman Sr program Manager
Sr program Manager Total investments: 1
Find email
Satyajit Mayor
Satyajit Mayor Co-Founder
Co-Founder Total investments: 0 Find email
Taslimarif Saiyed
Taslimarif Saiyed CEO and Director
CEO and Director Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
CrisprBits is an Indian company using CRISPR, a breakthrough gene-editing technology, to develop high-quality solutions in the life sciences that all Indians can afford. $3M / Seed / Nov 25, 2025
Aikenist is a healthcare technology firm that offers artificial intelligence-based medical imaging solutions for quicker scanning, better detection, and faster turnaround. AIkenist creates products that improve the end-to-end patient experience and maximize the utilization of medical equipment. AIkenist incorporates artificial intelligencecapabilities to produce quicker scanning, superior picture quality, and a better patient experience. Their founding team has strong entrepreneurial, engineering, and academic credentials, as well as experience in top management, product, and engineering positions in AI, biomedical, and cloud organizations.Aikenist was founded in 2019 and is headquartered in Bangalore, Karnataka. Seed / Oct 01, 2024
Farmroot Agritech is an one-stop solution provider that helps farmers from seed to harvest and allied marketing services. Grant / Jan 30, 2024
Janitri develops sustainable technology to improve maternal and child healthcare. $1.1M / Seed / May 02, 2023
Fibroheal Woundcare uses the biomaterial property of silk and silk protein to provide wound care management for acute, chronic, surgical, and traumatic wounds. Its products include sheets, mesh, foams, powder, and particles. $275.6K / Seed / Nov 29, 2022
Yostra Labs Private Limited is a healthcare technology firm pioneering smart innovations to make healthcare more effective, affordable and sustainable for the cost sensitive developing market. We are committed to solve pertinent healthcare issues through innovative, practical, and cutting edge technology solutions. $505.4K / Seed / Aug 16, 2022
SiCureMi is a medical device manufacturing company that specializes in the fields of vital signs monitoring and decision support. It aims to develop an affordable and non-invasive intelligent self-care product for users providing personalized care using predictive analytics from historical/real-time data using IOT/Mobile based app. $425K / Pre-Seed / Sep 22, 2021
SiCureMi is a medical device manufacturing company that specializes in the fields of vital signs monitoring and decision support. It aims to develop an affordable and non-invasive intelligent self-care product for users providing personalized care using predictive analytics from historical/real-time data using IOT/Mobile based app. $750K / Seed / Sep 22, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
Life Science
Food and Beverage
Publishing
LGBT
Mobile Apps
Wine and Spirits
Cannabis
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Celebrity
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Enterprise
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
LATAM
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Ecuador
Bolivia
Italy
Belize
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Belarus
Finland
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Centre for Cellular and Molecular Platforms invest in?

Centre for Cellular and Molecular Platforms invests primarily in Health Care, Medical and Manufacturing startups, most often at Seed and Grant stage. Most of the 8 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Centre for Cellular and Molecular Platforms's check size?

Centre for Cellular and Molecular Platforms typically joins rounds of $276k–$3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Centre for Cellular and Molecular Platforms participates in.

How do I contact Centre for Cellular and Molecular Platforms?

Public channels for Centre for Cellular and Molecular Platforms include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Centre for Cellular and Molecular Platforms?

The team at Centre for Cellular and Molecular Platforms includes Nitya Raman (Sr program Manager), Satyajit Mayor (Co-Founder) and Taslimarif Saiyed (CEO and Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Centre for Cellular and Molecular Platforms Centre for Cellular and Molecular Platforms Find emails